Antibody responses to tetanus toxoid and Haemophilus influenzae type b conjugate vaccines following autologous peripheral blood stem cell transplantation (PBSCT)

Bone Marrow Transplantation

Volumn 20, Issue 1, 1997, Pages 33-38

  Chan, C Y ^a   Molrine, D C ^a   Antin, J H ^b   Wheeler, C ^c   Guinan, E C ^a   Weinstein, H J ^a   Phillips, N R ^a   McGarigle, C ^b   Harvey, S ^c   Schnipper, C ^a   Ambrosino, D M ^a  

^a DANA FARBER CANCER INSTITUTE   (United States)

^b BRIGHAM AND WOMEN S HOSPITAL   (United States)

^c BETH ISRAEL DEACONESS MEDICAL CENTER   (United States)

Author keywords

Immunization, active; Peripheral blood stem cell transplantation; Vaccines, conjugate; Vaccines, protein

Indexed keywords

HAEMOPHILUS INFLUENZAE TYPE B VACCINE; IMMUNOGLOBULIN G ANTIBODY; TETANUS ANTIBODY; TETANUS TOXOID;

ADULT; ANTIBODY BLOOD LEVEL; ANTIBODY RESPONSE; ANTIGEN SPECIFICITY; ARTICLE; AUTOLOGOUS BONE MARROW TRANSPLANTATION; AUTOTRANSPLANTATION; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; FEMALE; GRANULOCYTE; HAEMOPHILUS INFLUENZAE; HUMAN; HUMORAL IMMUNITY; IMMUNITY; IMMUNIZATION; INTRAMUSCULAR DRUG ADMINISTRATION; LYMPHOMA; MALE; PERIPHERAL BLOOD STEM CELL; PRIORITY JOURNAL; STEM CELL TRANSPLANTATION; THROMBOCYTE;

EID: 0030877779     PISSN: 02683369     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.bmt.1700843     Document Type: Article

References (29)

1. Bortin MM, Horwitz MM, Gale RP. Current status of bone marrow transplantation in humans: report from the international bone marrow transplant registry. Nat Immun Cell Growth Regul 1988; 7: 334-350.
2. Storb R. Bone marrow transplantation: progress and problems. J Pediatr 1984; 105: 414-418.
3. Sullivan KM, Witherspoon RP, Storb R et al. Long-term results of allogeneic bone marrow transplantation. Transplant Proc 1989; 21: 2926-2928.
4. Barranger JA. Marrow transplantation in genetic disease. New Engl J Med 1984; 311: 1629-1631.
5. Leibundgut K, Hirt A, Luthy AR et al. Autotransplant with peripheral blood stem cells and clinical results obtained in children: a review. Eur J Pediatr 1993; 152: 546-554.
6. Barr RD, McBride JA. Hemopoietic engraftment with peripheral blood cells in the treatment of malignant disease. Br J Haematol 1982; 51: 181-187.
7. Lasky LC, Hurd DD, Smith JA, Haake R. Peripheral blood stem cell collection and use in Hodgkin's disease. Comparison with marrow in autologous transplantation. Transfusion 1989; 29: 323-327.
8. William SF, Bitran JD, Richards JM et al. Peripheral blood-derived stem cell collections for use in autologous transplantation after high-dose chemotherapy: an alternative approach. Bone Marrow Transplant 1990; 5: 129-133.
9. Kessinger A, Armitage JO, Landmark JD et al. Autologous peripheral hematopoietic stem cell transplantation restores hematopoietic function following marrow ablative therapy. Blood 1988; 71: 723-727.
10. Körbling M, Przepioka D, Huh YO et al. Allogeneic blood stem cell transplantation for refractory leukemia and lymphoma: potential advantage of blood over marrow allografts. Blood 1995; 85: 1659-1665.
11. Azevedo WM, Aranha FJP, Gouvea JV et al. Allogeneic transplantation with blood stem cells mobilized by rhG-CSF for hematological malignancies. Bone Marrow Transplant 1995; 16: 647-653.
12. Bensinger WI, Weaver CH, Appelbaum FR et al. Transplantation of allogeneic peripheral blood stem cells mobilized by recombinant human granulocyte colony-stimulating factor. Blood 1995; 85: 1655-1658.
13. Schmitz N, Dreger P, Suttorp M et al. Primary transplantation of allogeneic peripheral blood progenitor cells mobilized by filgrastim (granulocyte colony-stimulating factor). Blood 1995; 85: 1666-1672.
14. Henon PH, Liang H, Beck-Wirth G et al. Comparison of hematopoietic and immune recovery after autologous bone marrow or blood stem cell transplants. Bone Marrow Transplant 1992; 9: 285-291.
15. Janssen WE. Peripheral blood and bone marrow hematopoietic stem cells: are they the same? Semin Oncol 1993; 20 (Suppl. 6): 19-27.
16. To LB, Roberts MM, Haylock DN et al. Comparison of hematological recovery times and supportive care requirements of autologous recovery phase peripheral blood stem cell transplants, autologous bone marrow transplants and allogeneic bone marrow transplants. Bone Marrow Transplant 1992; 9: 277-284.
17. Takaue Y, Okamoto Y, Kawano Y et al. Regeneration of immunity and varicella-zoster virus infection after high-dose chemotherapy and peripheral blood stem cell autografts in children. Bone Marrow Transplant 1994; 14; 219-223.
18. Kiesel S, Pezzutto A, Moldenhauer G et al. B-cell proliferative and differentiation responses after autologous peripheral blood stem cell or bone marrow transplantation. Blood 1988; 72: 672-678.
19. Roberts MM, To LB, Gillis D et al. Immune reconstitution following peripheral blood stem cell transplantation, autologous bone marrow transplantation and allogeneic bone marrow transplantation. Bone Marrow Transplant 1993; 12: 469-475.
20. Siber GR, Ambrosino DM. Heavy and light chain restriction of human antibodies to polysaccharide antigens. In: Nydegger UE, Morell A (eds). Clinical Use of Intravenous Immunoglobulins. Academic Press: London, 1986, pp 47-55.
21. Käyhty H, Peltola H, Karanko V, Mäkelä PH. The protective level of serum antibodies to the capsular polysaccharide of Haemophilus influenzae type b. J Infect Dis 1983; 147: 1100.
22. Orenstein WA, Weisfeld JS, Halsey NA. Diphtheria and tetanus toxoids and pertussis vaccine, combined. Publication 451. Pan American Health Organization, World Health Organization: Washington, DC, 1983, p 30.
23. Ashihara E, Shimazaki C, Yamagata N et al. Reconstitution of lymphocyte subsets after peripheral blood stem cell transplantation: two color flow cytometric analyses. Bone Marrow Transplant 1994; 13: 377-381.
24. Peters WP, Rosner G, Ross M et al. Comparative effects of granulocyte-macrophage colony-stimulating factor (GM-CSF) and granulocyte colony-stimulating factor (G-CSF) on priming peripheral blood progenitor cells for use with autologous bone marrow after high-dose chemotherapy. Blood 1993; 81: 1709-1719.
25. Bensinger W, Singer J, Appelbaum F et al. Autologous transplantation with peripheral blood mononuclear cells collected after administration of recombinant granulocyte stimulating factor. Blood 1993; 81: 3158-3136.
26. Weaver CH, Hazelton B, Birch R et al. An analysis of engraftment kinetics as a function of the CD34 content of peripheral blood progenitor cell collection in 692 patients after the administration of myeloablative chemotherapy. Blood 1995; 86: 3961-3969.
27. + cells and unseparated peripheral blood progenitor cells mediate identical hematopoietic engraftment after high-dose VP16, ifosfamide, carboplatin, and epirubicin. Blood 1994; 84: 1421-1426.
28. Brugger W, Heimfeld S, Berenson RJ et al. Reconstitution of hematopoiesis after high-dose chemotherapy by autologous progenitor cells generated ex vivo. New Engl J Med 1995; 333: 283-287.
29. Broxmeyer HE, Hangoc G, Cooper S et al. Growth characteristics and expansion of human umbilical cord blood and estimation of its potential for transplantation in adults. Proc Natl Acad Sci USA 1992; 89: 4109-4113.